Rep. Val T. Hoyle Sells Off Shares of CME Group Inc. (NASDAQ:CME)

Representative Val T. Hoyle (D-Oregon) recently sold shares of CME Group Inc. (NASDAQ:CME). In a filing disclosed on October 10th, the Representative disclosed that they had sold between $1,001 and $15,000 in CME Group stock on September 23rd. The trade occurred in the Representative’s “FIDELITY ROLLOVER IRA” account.

Representative Val T. Hoyle also recently made the following trade(s):

  • Sold $1,001 – $15,000 in shares of Marriott International (NASDAQ:MAR) on 9/23/2025.
  • Sold $1,001 – $15,000 in shares of Transdigm Group (NYSE:TDG) on 9/23/2025.
  • Sold $1,001 – $15,000 in shares of H&R Block (NYSE:HRB) on 9/23/2025.
  • Sold $1,001 – $15,000 in shares of NIKE (NYSE:NKE) on 9/23/2025.
  • Sold $1,001 – $15,000 in shares of Bank of New York Mellon (NYSE:BK) on 9/23/2025.
  • Sold $1,001 – $15,000 in shares of Cisco Systems (NASDAQ:CSCO) on 9/23/2025.
  • Sold $1,001 – $15,000 in shares of Capital One Financial (NYSE:COF) on 9/23/2025.
  • Sold $1,001 – $15,000 in shares of Pentair (NYSE:PNR) on 9/23/2025.
  • Sold $1,001 – $15,000 in shares of Heico (NYSE:HEI.A) on 9/23/2025.
  • Sold $1,001 – $15,000 in shares of Target (NYSE:TGT) on 9/23/2025.

CME Group Stock Performance

Shares of CME opened at $271.45 on Friday. CME Group Inc. has a 12 month low of $213.94 and a 12 month high of $290.79. The firm has a fifty day simple moving average of $268.89 and a 200 day simple moving average of $271.22. The stock has a market capitalization of $97.83 billion, a price-to-earnings ratio of 26.28, a PEG ratio of 5.72 and a beta of 0.41. The company has a current ratio of 1.02, a quick ratio of 1.02 and a debt-to-equity ratio of 0.12.

CME Group (NASDAQ:CMEGet Free Report) last announced its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 EPS for the quarter, beating analysts’ consensus estimates of $2.91 by $0.05. The firm had revenue of $1.69 billion during the quarter, compared to analysts’ expectations of $1.68 billion. CME Group had a net margin of 58.48% and a return on equity of 14.60%. The company’s revenue for the quarter was up 10.4% compared to the same quarter last year. During the same quarter last year, the company posted $2.56 earnings per share. Research analysts forecast that CME Group Inc. will post 10.49 EPS for the current fiscal year.

CME Group Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were issued a dividend of $1.25 per share. The ex-dividend date was Tuesday, September 9th. This represents a $5.00 annualized dividend and a yield of 1.8%. CME Group’s dividend payout ratio is presently 48.40%.

Analysts Set New Price Targets

CME has been the subject of a number of recent analyst reports. UBS Group cut their price target on shares of CME Group from $305.00 to $285.00 and set a “neutral” rating for the company in a research note on Monday, September 8th. Citigroup upgraded shares of CME Group from a “neutral” rating to a “buy” rating and increased their price target for the company from $275.00 to $300.00 in a research note on Thursday, September 25th. Barclays cut their price target on shares of CME Group from $298.00 to $280.00 and set an “equal weight” rating for the company in a research note on Wednesday. Weiss Ratings reiterated a “buy (b)” rating on shares of CME Group in a research note on Wednesday. Finally, Piper Sandler increased their price target on shares of CME Group from $283.00 to $296.00 and gave the company an “overweight” rating in a research note on Tuesday, July 15th. Seven equities research analysts have rated the stock with a Buy rating, seven have issued a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $281.00.

Check Out Our Latest Analysis on CME

Hedge Funds Weigh In On CME Group

Several large investors have recently modified their holdings of CME. Wayfinding Financial LLC bought a new position in shares of CME Group in the first quarter valued at about $25,000. Webster Bank N. A. increased its position in CME Group by 206.9% during the second quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock worth $25,000 after acquiring an additional 60 shares during the period. Cornerstone Planning Group LLC increased its holdings in CME Group by 122.2% in the 1st quarter. Cornerstone Planning Group LLC now owns 100 shares of the financial services provider’s stock valued at $26,000 after buying an additional 55 shares during the period. Highline Wealth Partners LLC increased its holdings in CME Group by 84.3% in the 2nd quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after buying an additional 43 shares during the period. Finally, Golden State Wealth Management LLC increased its holdings in CME Group by 612.5% in the 1st quarter. Golden State Wealth Management LLC now owns 114 shares of the financial services provider’s stock valued at $30,000 after buying an additional 98 shares during the period. 87.75% of the stock is owned by institutional investors.

Insider Activity

In other news, insider Sunil Cutinho sold 11,896 shares of the business’s stock in a transaction that occurred on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total value of $3,229,407.12. Following the transaction, the insider owned 17,440 shares in the company, valued at approximately $4,734,436.80. The trade was a 40.55% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, General Counsel Jonathan L. Marcus sold 392 shares of the business’s stock in a transaction that occurred on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total transaction of $102,704.00. Following the completion of the transaction, the general counsel owned 7,851 shares in the company, valued at $2,056,962. This trade represents a 4.76% decrease in their position. The disclosure for this sale can be found here. Insiders sold 13,043 shares of company stock valued at $3,527,956 in the last 90 days. 0.30% of the stock is owned by corporate insiders.

About Representative Hoyle

Val Hoyle (Democratic Party) is a member of the U.S. House, representing Oregon’s 4th Congressional District. She assumed office on January 3, 2023. Her current term ends on January 3, 2027.

Hoyle (Democratic Party) is running for re-election to the U.S. House to represent Oregon’s 4th Congressional District. She declared candidacy for the 2026 election.

Val Hoyle was born in California and lives in Springfield, Oregon. Hoyle graduated from Merrimack High School. She earned a B.A. in political science from Emmanuel College in 1992. Her career experience includes working as a director at United Way of Lane County, a policy fellow at Wayne Morse Center for Law and Politics, and a commissioner at the Oregon Bureau of Labor and Industries. Hoyle has also worked in domestic and international sales, as well as manufacturing distribution.

CME Group Company Profile

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Recommended Stories

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.